SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-018968
Filing Date
2020-10-06
Accepted
2020-10-06 06:08:45
Documents
13
Period of Report
2020-10-06
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 32359
2 ex99-1.htm EX-99.1 8240
3 ex99-1_001.jpg GRAPHIC 98034
4 ex99-1_002.jpg GRAPHIC 172026
5 ex99-1_003.jpg GRAPHIC 192460
6 ex99-1_004.jpg GRAPHIC 143897
7 ex99-1_005.jpg GRAPHIC 188034
8 ex99-1_006.jpg GRAPHIC 89813
9 ex99-1_007.jpg GRAPHIC 120204
10 ex99-1_008.jpg GRAPHIC 88181
11 ex99-1_009.jpg GRAPHIC 230562
12 ex99-1_010.jpg GRAPHIC 177647
13 ex99-1_011.jpg GRAPHIC 97834
  Complete submission text file 0001493152-20-018968.txt   2244658
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21617 | Film No.: 201225519
SIC: 2834 Pharmaceutical Preparations